Affiliation:
1. National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy
Abstract
Demyelinating diseases are a group of pathologies characterized by the alteration of myelin—that is, the coating that wraps around most of the nerve fibres of the central and peripheral nervous system, whose goal is the improvement of nerve conduction and the preservation of energy spent during action potential propagation [...]
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference8 articles.
1. Special Issue “Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies”. Int. J. Mol. Sci., Available online: https://www.mdpi.com/journal/ijms/special_issues/demyelinating_diseases.
2. Balestri, S., Del Giovane, A., Sposato, C., Ferrarelli, M., and Ragnini-Wilson, A. (2021). The Current Challenges for Drug Discovery in CNS Remyelination. Int. J. Mol. Sci., 22.
3. Kim, B.S. (2021). Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler’s Virus-Induced Demyelinating Disease. Int. J. Mol. Sci., 22.
4. Khodanovich, M.Y., Kamaeva, D.A., and Naumova, A.V. (2022). Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19. Int. J. Mol. Sci., 23.
5. Guerriero, C., Puliatti, G., Di Marino, T., and Tata, A.M. (2022). Effects Mediated by Dimethyl Fumarate on In Vitro Oligodendrocytes: Implications in Multiple Sclerosis. Int. J. Mol. Sci., 23.